At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 60 enrolled
Drug / intervention
Remifentanil +5 moredrug
Likely dose
Remifentanil 0.4 mcg/kgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Remifentanil Only vs. Combination Group Midazolam + Meperidine During Elective Colonoscopy
In Brief
A Phase 4 clinical trial evaluating Remifentanil, Midazolam, and 4 other interventions for Diagnostic Colonoscopy Screening. Completed, enrolled 60 participants across 1 site.
Detailed Summary
The aim of the present study is to compare patient's recovery times after elective colonoscopy employing remifentanil only vs conventional combination of midazolam and meperidine
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiagnostic Colonoscopy Screening
CountriesSouth Korea
CollaboratorsGlaxoSmithKline
Timeline
Phase 4CompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedSep 2012
Enrollment StartDec 2012
Primary CompletionFeb 2013
Study CompletionAug 2013
TodayJul 2026
First PostedSep 26, 2012
Enrollment StartDec 1, 2012
Primary CompletionFeb 1, 2013
Study CompletionAug 1, 2013
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 13.8 years ago
Interventions
Remifentanildrug
continuous infusion 0.4 mcg/kg/min
Midazolamdrug
bolus injection
Meperidinedrug
bolus injection for 30 sec 1.0 mg/kg
placebo (for remifentanil)drug
normal saline mimic diluted remifentanil
placebo (for midazolam)drug
normal saline mimic to midazolam injection
placebo (for meperidine)drug
normal saline mimic meperidine injection